We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
-0.86%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.14B
AUM Growth
-$165M
(-13%)
Cap. Flow
-$89.3M
Cap. Flow
% of AUM
-7.83%
Top 10 Holdings %
Top 10 Hldgs %
42.55%
Holding
55
New
5
Increased
22
Reduced
16
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FNA
Paragon 28, Inc.
FNA
|
+$37M |
| 2 |
LivaNova
LIVN
|
+$34.6M |
| 3 |
Evolent Health
EVH
|
+$29.5M |
| 4 |
Vera Therapeutics
VERA
|
+$22.6M |
| 5 |
Health Catalyst
HCAT
|
+$20.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$52.6M |
| 2 |
Transmedics
TMDX
|
+$49.3M |
| 3 |
iRhythm Holdings
IRTC
|
+$48.8M |
| 4 |
Natera
NTRA
|
+$29.2M |
| 5 |
MODN
MODEL N, INC.
MODN
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 97.29% |
| 2 | Industrials | 2.71% |
| 3 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNA
1
DELISTED
Paragon 28, Inc.
FNA
| $55.9M | 4.9% |
8,174,832
+4,371,864
| +115% | +$37M |
|
2
Alphatec Holdings
ATEC
$1.46B
| $55.7M | 4.88% |
5,327,978
-90,653
| -2% | -$1.06M |
|
3
Crinetics Pharmaceuticals
CRNX
$8.84B
| $53.8M | 4.71% |
1,200,508
-489,669
| -29% | -$22.6M |
|
4
NeoGenomics
NEO
$1.96B
| $52.5M | 4.6% |
3,782,561
+480,396
| +15% | +$6.81M |
|
5
Xenon Pharmaceuticals
XENE
$6.06B
| $50.9M | 4.46% |
1,306,260
-13,912
| -1% | -$556K |
|
|
6
Transmedics
TMDX
$2.64B
| $45.3M | 3.97% |
300,600
-411,082
| -58% | -$49.3M |
|
7
AtriCure
ATRC
$1.92B
| $44.7M | 3.92% |
1,964,703
+581,843
| +42% | +$13.4M |
|
8
Insulet
PODD
$11.5B
| $43.5M | 3.81% |
215,637
+64,373
| +43% | +$11.6M |
|
|
CNTA
9
DELISTED
Centessa Pharmaceuticals
CNTA
| $43.2M | 3.78% |
4,780,560
+1,778,515
| +59% | +$16.9M |
|
|
10
Natera
NTRA
$38.3B
| $40M | 3.5% |
369,068
-287,640
| -44% | -$29.2M |
|
11
Ultragenyx Pharmaceutical
RARE
$2.45B
| $39.6M | 3.47% |
963,146
+172,700
| +22% | +$7.37M |
|
|
12
LivaNova
LIVN
$4.4B
| $38.9M | 3.41% |
710,390
+607,598
| +591% | +$34.6M |
|
13
Insmed
INSM
$21.4B
| $36.9M | 3.24% |
551,303
+268,537
| +95% | +$10.4M |
|
14
Pliant Therapeutics
PLRX
$64.4M
| $36.6M | 3.21% |
3,401,213
-133,780
| -4% | -$1.72M |
|
|
15
Vera Therapeutics
VERA
$2.3B
| $36.4M | 3.19% |
1,005,723
+569,590
| +131% | +$22.6M |
|
16
SI-BONE Inc
SIBN
$788M
| $32M | 2.8% |
2,473,289
+124
| +0% | +$1.77K |
|
|
RCM
17
DELISTED
R1 RCM Inc. Common Stock
RCM
| $31M | 2.71% |
2,464,809
-87,516
| -3% | -$1.09M |
|
|
PHLT
18
DELISTED
Performant Healthcare Inc
PHLT
| $30.5M | 2.67% |
10,514,200
-927
| -0% | -$2.66K |
|
19
Oscar Health
OSCR
$9.41B
| $29.5M | 2.59% |
1,865,922
-236,632
| -11% | -$4.35M |
|
20
Tandem Diabetes Care
TNDM
$1.34B
| $28.5M | 2.5% |
708,482
+233,405
| +49% | +$9.74M |
|
|
BCYC
21
Bicycle Therapeutics
BCYC
$269M
| $28M | 2.46% |
1,384,768
+191,717
| +16% | +$4.33M |
|
|
22
Evolent Health
EVH
$348M
| $27.6M | 2.42% |
1,445,305
+1,157,124
| +402% | +$29.5M |
|
|
23
Health Catalyst
HCAT
$154M
| $25.3M | 2.22% |
3,956,089
+3,221,408
| +438% | +$20.7M |
|
24
Axogen
AXGN
$2.27B
| $24.2M | 2.12% |
3,344,033
+2,578,147
| +337% | +$17.6M |
|
25
Structure Therapeutics
GPCR
$3.41B
| $23.2M | 2.03% |
590,647
+441,534
| +296% | +$18.1M |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q2 2024 Portfolio in Review
As of Q2 2024, First Light Asset Management held 55 positions worth $1.14B, down 13% from $1.31B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
First Light Asset Management withdrew a net $89.3M in Q2 2024, closing 11 positions and reducing 16 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $52.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 96% a quarter earlier, followed by Industrials and Communication Services.
Against the trend, First Light Asset Management opened a new position in Savara worth $8.07M.
- First Light Asset Management's largest Q2 2024 buy was Savara: 2,002,219 shares worth $8.07M.
- First Light Asset Management added most to Paragon 28, Inc. in Q2 2024, an estimated $37M increase.
- First Light Asset Management's biggest Q2 2024 reduction was Transmedics, cutting an estimated $49.3M.
- First Light Asset Management fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $52.6M.
- First Light Asset Management's ten largest holdings make up 43% of its $1.14B portfolio in Q2 2024.
- First Light Asset Management opened 5 new positions and closed 11 in Q2 2024.
- First Light Asset Management's portfolio value fell 13% quarter-over-quarter to $1.14B.
Based on First Light Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.